J&J’s Varipulse system achieves freedom for atrial arrhythmia recurrence
J&J MedTech’s Varipulse Platform demonstrated 12-month freedom from atrial arrhythmia recurrence in approximately 80% of the patients in inspIRE and admIRE trials.
05 February 2024
05 February 2024
J&J MedTech’s Varipulse Platform demonstrated 12-month freedom from atrial arrhythmia recurrence in approximately 80% of the patients in inspIRE and admIRE trials.
The study assessed the safety, efficiency and accuracy of predictive pre-planning with FEops HEARTguide.
The new technology merges with current retinal cameras, offering real-time cardiovascular disease (CVD) risk evaluations.
The EVOQUE system is intended for patients with symptomatic severe tricuspid regurgitation (TR).
Visage Ease VP supports diagnostic imaging and multimedia experiences, leveraging the capabilities of Apple Vision Pro.
A total of 40 patients with resistant hypertension will be involved in the study as the renal denervation space attracts new joiners.
Virtual Incision’s MIRA Surgical System is described by the company as the first miniaturised robotic-assisted surgery (miniRAS).
Avation’s Vivally system is a wearable neuromodulation device for at-home treatment of urinary incontinence and urinary urgency caused by overactive bladder syndrome.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.